Stocks to sell

There’s no doubt about it: XPeng (NYSE:XPEV) wants the world to know that the company just unveiled a new SUV. That’s all fine and well, but was this event enough to assuage investors’ concerns about XPeng? So far, the answer is no. The Chinese automakers’ dwindling deliveries, along with macroeconomic issues, are legitimate issues and could

The Fed’s key interest rate target now stands at 3%-3.25%, way up from 0%-0.25% at the beginning of the year. That means, for all companies, borrowing money is becoming much more expensive. As a result, healthcare companies losing a great deal of money will have trouble obtaining new loans they can afford to pay off, and

It’s been a tumultous couple of years of real estate stocks. The pandemic caused unprecedented changes in people’s daily lives and working habits. Some categories of real estate investment trusts (REITs) benefitted from these adjustments. Sub-sectors such as data centers and industrial warehouses enjoyed a surge in demand during the pandemic period. Many categories of

This year will probably go down as the roughest year for investors since the financial recession in 2008. The S&P 500 has shed more than 20% of its value year-to-date as inflation and interest rates weigh down the equities market. Hence, investors are scrambling to streamline their portfolios. In doing so, they might want to

With stocks still in a bear market, adding dividend stocks may look very appealing right now. Even if the overall market keeps dropping, stocks with steady payouts could still produce positive returns for your portfolio. However, while there are opportunities out there for income-focused investors, there are also plenty of dividend stocks to sell if

This year, consumer stocks have been hammered as inflation lingers at 40-year highs and interest rates rise. The Dow Jones U.S. Consumer Goods Index is down 20% this year as consumers pull back on their spending. However, some consumer-focused companies have performed worse than others. Much worse.  Whether it is due to poor management, failure to adapt

Changing market conditions over the past year have had a severe impact on the performance of Luminar Technologies (NASDAQ:LAZR) stock. In 2020 and 2021, when investors were in “growth at any price” mode, shares in this provider of self-driving technology to the automotive industry were flying high. But with the shift in market sentiment about

Novavax (NASDAQ:NVAX) stock hasn’t had a great 2022, down 86% since the beginning of the year. The company focuses on products to treat infectious diseases but is definitely best known for its Covid-19 vaccine NVX-CoV2373, also known as Nuvaxovid. There are plenty of other competing vaccines in this category, and Novavax’s shots haven’t been strong sellers

There’s been some drama surrounding Cassava Sciences (NASDAQ:SAVA) recently. First, there was a report stating that the Securities and Exchange Commission, or SEC, cleared Cassava Sciences of charges of manipulating research results. Not long afterward, however, Cassava disputed the legitimacy of that report. These twists and turns in the ongoing story make it difficult to recommend

After months in the stock market’s graveyard, American Virtual Cloud Technologies (NASDAQ:AVCT) stock has more than doubled in price since Aug. 26. It’s difficult to prove, but it seems as if the meme crowd, who have dabbled in this cloud communications play before, once again sees the opportunity to make a quick buck. Conversation online

If you feel like housing prices are out of control, you’re not alone. A Pew Research survey conducted in 2021 found that half of Americans now consider the lack of affordable housing as a “major” problem, up from 39% in 2017. (Only 14% of Americans think it is not a problem at all). Since then,

As people acclimatize to the new normal, it’s time to look at some vaccine stocks to sell. Instead of relying primarily on vaccines and antiviral drugs, the government let people manage infections. Once infected with the less fatal strain, Omicron, people would isolate themselves for a few days and then return to work. By shifting

As is typical of a bear market, the Nasdaq has led the other major indices lower over the past year. The tech-heavy index is down 28% over the past 12 months compared with a 17% decline in the S&P 500. There are bargains to be found amid the tech wreckage to be sure. But there

Sometimes, you just have to let go of a thesis when it’s proven wrong. Stubborn investors might try to average down on microprocessor manufacturer Intel (NASDAQ:INTC) stock. That’s not a wise move to make, though, as even the company’s management had to acknowledge challenging market conditions. If you’re only in it for the dividend payouts, don’t

Usually, the winter season brings levity to people as the holidays approach, but the chilly economic nature this year brings up the uncomfortable topic of retail stocks to sell. Fundamentally, Federal Reserve Chair Jerome Powell indicated that his top priority is controlling inflation. What’s more, Powell made good on his statements, with the central bank

Lyft (NASDAQ:LYFT) stock was hit hard by the Covid-19 pandemic but is now trying to stage a recovery. This won’t be easy, however, as Lyft is facing not just one, but multiple lawsuits over alleged assaults. This could put negative pressure on LYFT stock, and so could scrutiny from the Federal Trade Commission or FTC concerning

As corporate earnings go, so goes the stock market. And indications are that we’re running into trouble. As a result, there are many stocks to sell. Over the past few weeks several leading U.S. companies have issued negative pre-announcements, lowered or pulled their forward guidance, implemented cost cuts, and warned of more pain ahead. The

Over the past two months, sentiment for FuboTV (NYSE:FUBO) stock has gone from “game over” to “game on.” Hitting a new low of $2.32 per share in late July, FUBO stock briefly spiked to above $6 per share in August as the result of an extremely positive response its first investor day presentation. Although this

When a company’s CEO is frustrated, that’s probably not a good sign for investors. Today’s case in point is Palantir Technologies (NYSE:PLTR) stock, which seems to be having difficulty with some government contracts as their timing can be problematic. Furthermore, Palantir’s disappointing forward guidance could easily be a deal-breaker for prospective PLTR stock investors. Don’t get

Bullish analyst ratings and activist involvement have helped to shift sentiment for PayPal (NASDAQ:PYPL), resulting in a rebound for PYPL stock since July. After falling to as low as $67.60 per share, it’s climbed back up to the mid-$90s per share. That’s around a 36% increase in fewer than three months. With this bounceback, should